GentiBio, Inc., is an early stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory and allergic diseases. GentiBio's proprietary autologous and allogeneic EngTregs platform integrates key complimentary technologies needed to successfully restore immune tolerance and overcome major limitations in existing regulatory T-cell therapeutics. GentiBio is at the forefront of leveraging a unique therapeutic modality that can be used to address the fundamental cause of many diseases that result from overshooting and/or malfunctioning of the immune system.
View Top Employees from GentiBioWebsite | http://www.gentibio.com |
Employees | 91 (91 on RocketReach) |
Founded | 2020 |
Address | 150 Cambridgepark Dr, Cambridge, Massachusetts 02140, US |
Technologies |
JavaScript,
HTML,
PHP
+11 more
(view full list)
|
Industry | Biotechnology, Drug Discovery |
Looking for a particular GentiBio employee's phone or email?
91 people are employed at GentiBio.
GentiBio is based in Cambridge, Massachusetts.